Advertisement

Studies of NMR, molecular docking, and molecular dynamics simulation of new promising inhibitors of cruzaine from the parasite Trypanosoma cruzi

  • Renato A. Costa
  • Jorddy N. CruzEmail author
  • Fabiana C. A. Nascimento
  • Sebastião G. Silva
  • Silvana O. Silva
  • Marlice C. Martelli
  • Samira M. L. Carvalho
  • Cleydson B. R. Santos
  • Antonio M. J. C. Neto
  • Davi S. B. Brasil
Original Research
  • 39 Downloads

Abstract

Cruzaine is the major cysteine protease of Trypanosoma cruzi. Cruzaine is involved throughout the parasite’s life cycle in host cells, and is a promising target in the search for new antichagasic agents. Quantum chemical calculations based on density functional theory (DFT B3LYP/cc-pVDZ) were performed to obtain nuclear magnetic resonance data and to optimize the geometry of four dihydrochalcones. The results showed good agreement with the experimental data and were used to suggest the relative stereochemistry of one of the four dihydrochalcones studied. In addition, we evaluated the interaction of cruzaine with these new inhibitors. We used molecular dynamics simulations, free energy calculations, and a per-residue energy decomposition method. It was observed that these molecules are capable of interacting with residues important for enzymatic activity, like Cys25, His161, and Asp160. The ranking of the inhibitors obtained from the binding free energy calculations is in agreement with that experimentally reported. The evaluation of the energy components involved in these calculations demonstrated that the van der Waals term is the major contributor to the drug–receptor stabilizing interactions.

Keywords

RMN New inhibitors Cruzaine Docking Molecular dynamics 

Notes

Acknowledgements

Jorddy N. Cruz appreciate the support of the Federal University of Pará and the National Council for Scientific and Technological Development (CNPq). Conflict of interest The authors declare that there is no conflict of interest regarding the publication of this paper.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

44_2018_2280_MOESM1_ESM.png (299 kb)
Supplementary Figure S1
44_2018_2280_MOESM2_ESM.png (291 kb)
Supplementary Figure S2
44_2018_2280_MOESM3_ESM.png (510 kb)
Supplementary Figure S3
44_2018_2280_MOESM4_ESM.docx (18 kb)
Supplementary information

References

  1. A Khan J, Wahab A, Javaid S, AL-Ghamdi M, Huwait E, Shaikh M, Shafqat A, Choudhary MI (2017) Studies on new urease inhibitors by using biochemical, STD-NMR spectroscopy, and molecular docking methods. Med Chem Res 26:2452–2467CrossRefGoogle Scholar
  2. Arafet K, Ferrer S, Moliner V (2017) Computational study of the catalytic mechanism of the cruzain cysteine protease. ACS Catal 7:1207–1215CrossRefGoogle Scholar
  3. Borges RS, Vale JKL, Pereira GAN, Veiga AAS, Junior JB, da Silva ABF, L Vale JK, N Pereira GA, S Veiga AA, Batista Jr. J, F da Silva AB (2016) An antioxidant mechanism of morphine and related derivatives. Med Chem Res 25:852–857CrossRefGoogle Scholar
  4. Brak K, Doyle PS, McKerrow JH, Ellman JA (2008) Identification of a new class of nonpeptidic inhibitors of cruzain. J Am Chem Soc 130:6404–6410CrossRefGoogle Scholar
  5. Brasil DSB, Alves CN, Guilhon GMSP, Muller AH, de S. Secco R, Peris G, Llusar R (2008) Crystal structure and theoretical study of IR and 1H and 13C NMR spectra of cordatin, a natural product with antiulcerogenic activity. Int J Quantum Chem 108:2564–2575CrossRefGoogle Scholar
  6. Burger MC, de M, Fernandes JB, da Silva MF, das GF, Escalante A, Prudhomme J, Le Roch KG, Izidoro MA, Vieira PC (2014) Structures and bioactivities of dihydrochalcones from Metrodorea stipularis. J Nat Prod 77:2418–2422CrossRefGoogle Scholar
  7. Caputto ME, Fabian LE, Benítez D, Merlino A, Ríos N, Cerecetto H, Moltrasio GY, Moglioni AG, González M, Finkielsztein LM (2011) Thiosemicarbazones derived from 1-indanones as new anti-Trypanosoma cruzi agents. Bioorg Med Chem 19:6818–26CrossRefGoogle Scholar
  8. Carneiro CM, Sánchez-Montalvá A, Corrêa-Oliveira R, Sales Jr. PA, Fonseca Murta SM, Salvador F, Molina I (2017) Experimental and clinical treatment of chagas disease: A review. Am J Trop Med Hyg 97:1289–1303CrossRefGoogle Scholar
  9. Case DA, Cheatham TE, Darden T, Gohlke H, Luo R, Merz KM, Onufriev A, Simmerling C, Wang B, Woods RJ (2005) The Amber biomolecular simulation programs. J Comput Chem 26:1668–1688CrossRefGoogle Scholar
  10. Chagas C, Chagas C (1909) Nova tripanozomiaze humana: estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem. Mem Inst Oswaldo Cruz 1:159–218CrossRefGoogle Scholar
  11. Chatelain E (2017) Chagas disease research and development: Is there light at the end of the tunnel? Comput Struct Biotechnol J 15:98–103CrossRefGoogle Scholar
  12. Cimino P, Gomez-Paloma L, Duca D, Riccio R, Bifulco G (2004) Comparison of different theory models and basis sets in the calculation of 13C NMR chemical shifts of natural products. Magn Reson Chem 42:S26–S33CrossRefGoogle Scholar
  13. Cornell WD, Cieplak P, Bayly CI, Kollman PA (1993) Application of RESP charges to calculate conformational energies, hydrogen bond energies, and free energies of solvation. J Am Chem Soc 115:9620–9631CrossRefGoogle Scholar
  14. Coura JR (2015) The main sceneries of Chagas disease transmission. The vectors, blood and oral transmissions-a comprehensive review. Mem Inst Oswaldo Cruz 110:277–82CrossRefGoogle Scholar
  15. Cruz JN, Costa JFS, Khayat AS, Kuca K, Barros CAL, Neto AMJC (2018) Molecular dynamics simulation and binding free energy studies of novel leads belonging to the benzofuran class inhibitors of Mycobacterium tuberculosis polyketide synthase 13. J Biomol Struct Dyn 5:1–12CrossRefGoogle Scholar
  16. Darden T, York D, Pedersen L (1993) Particle mesh Ewald: An N ⋅log(N) method for Ewald sums in large systems. J Chem Phys 98:10089–10092CrossRefGoogle Scholar
  17. Dennington R, Keith TA, Millam JM (2015) GaussView Version 5 Semichem Inc., Shawnee Mission, KS.Google Scholar
  18. Dolinsky TJ, Nielsen JE, McCammon JA, Baker NA (2004) PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Res 32:W665–W667CrossRefGoogle Scholar
  19. Farady CJ, Craik CS (2010) Mechanisms of macromolecular protease inhibitors. Chembiochem 11:2341–6CrossRefGoogle Scholar
  20. Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Scalmani G, Barone V, Mennucci B, Petersson GA, Nakatsuji H, Caricato M, Li X, Hratchian HP, Izmaylov AF, Bloino J, Zheng G, Sonnenberg JL, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Vreven T, Montgomery JA, Peralta JE, Ogliaro F, Bearpark M, Heyd JJ, Brothers E, Kudin KN, Staroverov VN, Kobayashi R, Normand J, Raghavachari K, Rendell A, Burant JC, Iyengar SS, Tomasi J, Cossi M, Rega N, Millam JM, Klene M, Knox JE, Cross JB, Bakken V, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Martin RL, Morokuma K, Zakrzewski VG, Voth GA, Salvador P, Dannenberg JJ, Dapprich S, Daniels AD, Farkas, Foresman JB, Ortiz JV, Cioslowski J, Fox DJ (2009) Gaussian 09, Revision B.01. Gaussian, Inc., Wallingford, CTGoogle Scholar
  21. Gauss J, Stanton JF (1995) Gauge‐invariant calculation of nuclear magnetic shielding constants at the coupled–cluster singles and doubles level. J Chem Phys 102:251–253CrossRefGoogle Scholar
  22. Genheden S, Ryde U (2015) The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov 10:449–461CrossRefGoogle Scholar
  23. Gohlke H, Kiel C, Case DA (2003) Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes. J Mol Biol 330:891–913CrossRefGoogle Scholar
  24. Huang L, Brinen LS, Ellman JA (2003) Crystal structures of reversible ketone-Based inhibitors of the cysteine protease cruzain. Bioorg Med Chem 11:21–29CrossRefGoogle Scholar
  25. Izaguirre JA, Catarello DP, Wozniak JM, Skeel RD (2001) Langevin stabilization of molecular dynamics. J Chem Phys 114:2090–2098CrossRefGoogle Scholar
  26. Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79:926–935CrossRefGoogle Scholar
  27. Kaur K, Kumar V, Beniwal V, Kumar V, Aneja KR, Sharma V, Jaglan S (2015) Solvent-free synthesis of novel (E)-2-(3,5-dimethyl-4-(aryldiazenyl)-1H-pyrazol-1-yl)-4-arylthiazoles: determination of their biological activity. Med Chem Res 24:3863–3875CrossRefGoogle Scholar
  28. Kollman PA, Massova I, Reyes C, Kuhn B, Huo S, Chong L, Lee M, Lee T, Duan Y, Wang W, Donini O, Cieplak P, Srinivasan J, Case DA, Cheatham TE (2000) Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res 33:889–97CrossRefGoogle Scholar
  29. Laskowski M, Qasim MA (2000) What can the structures of enzyme-inhibitor complexes tell us about the structures of enzyme substrate complexes? Biochim Biophys Acta-Protein Struct Mol Enzymol 1477:324–337CrossRefGoogle Scholar
  30. Lee C, Yang W, Parr RG (1988) Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Phys Rev B Condens Matter 37:785–789CrossRefGoogle Scholar
  31. Magalhaes Moreira DR, de Oliveira ADT, Teixeira de Moraes Gomes PA, de Simone CA, Villela FS, Ferreira RS, da Silva AC, dos Santos TAR, Brelaz de Castro MCA, Pereira VRA, Leite ACL (2014) Conformational restriction of aryl thiosemicarbazones produces potent and selective anti-Trypanosoma cruzi compounds which induce apoptotic parasite death. Eur J Med Chem 75:467–478CrossRefGoogle Scholar
  32. Maier JA, Martinez C, Kasavajhala K, Wickstrom L, Hauser KE, Simmerling C (2015) ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB. J Chem Theory Comput 11:3696–3713CrossRefGoogle Scholar
  33. Massarico Serafim RA, Gonçalves JE, de Souza FP, de Melo Loureiro AP, Storpirtis S, Krogh R, Andricopulo AD, Dias LC, Ferreira EI (2014) Design, synthesis and biological evaluation of hybrid bioisoster derivatives of N-acylhydrazone and furoxan groups with potential and selective anti-Trypanosoma cruzi activity. Eur J Med Chem 82:418–425CrossRefGoogle Scholar
  34. McGrath ME, Eakin AE, Engel JC, McKerrow JH, Craik CS, Fletterick RJ (1995) The crystal structure of cruzain: A therapeutic target for Chagas’ disease. J Mol Biol 247:251–259CrossRefGoogle Scholar
  35. Miertuš S, Scrocco E, Tomasi J (1981) Electrostatic interaction of a solute with a continuum. A direct utilizaion of AB initio molecular potentials for the prevision of solvent effects. Chem Phys 55:117–129CrossRefGoogle Scholar
  36. Moreira RYO, Brasil DSB, Alves CN, Guilhon GMSP, Santos LS, Arruda MSP, Müller AH, Barbosa PS, Abreu AS, Silva EO, Rumjanek VM, Souza J, da Silva ABF, Santos RH, de A (2008) Crystal structure and theoretical calculations of Julocrotine, a natural product with antileishmanial activity. Int J Quantum Chem 108:513–520CrossRefGoogle Scholar
  37. Morillo CA, Marin-Neto JA, Avezum A, Sosa-Estani S, Rassi A, Rosas F, Villena E, Quiroz R, Bonilla R, Britto C, Guhl F, Velazquez E, Bonilla L, Meeks B, Rao-Melacini P, Pogue J, Mattos A, Lazdins J, Rassi A, Connolly SJ, Yusuf S (2015) Randomized trial of benznidazole for chronic chagas’ cardiomyopathy. N Engl J Med 373:1295–1306CrossRefGoogle Scholar
  38. Pérez-Molina JA, Molina I (2018) Chagas disease. Lancet (Lond, Engl) 391:82–94CrossRefGoogle Scholar
  39. Rauhut G, Puyear S, Wolinski K, Pulay P (1996) Comparison of NMR shieldings calculated from Hartree−Fock and density functional wave functions using gauge-including atomic orbitals. J Phys Chem 100:6310–6316CrossRefGoogle Scholar
  40. Ryckaert JP, Ciccotti G, Berendsen HJC (1977) Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J Comput Phys 23:327–341CrossRefGoogle Scholar
  41. Serafim RAM, de Oliveira TF, Loureiro APM, Krogh R, Andricopulo AD, Dias LC, Ferreira EI (2017) Molecular modeling and structure–activity relationships studies of bioisoster hybrids of N-acylhydrazone and furoxan groups on cruzain. Med Chem Res 26:760–769CrossRefGoogle Scholar
  42. Thomsen R, Christensen MH (2006) MolDock: A new technique for high-accuracy molecular docking. J Med Chem 49:3315–3321CrossRefGoogle Scholar
  43. Turk D, Guncar G, Podobnik M, Turk B (1998) Revised definition of substrate binding sites of papain-like cysteine proteases. Biol Chem 379:137–47CrossRefGoogle Scholar
  44. Wang J, Cieplak P, Kollman PA (2000) How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules? J Comput Chem 21:1049–1074CrossRefGoogle Scholar
  45. Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA (2004) Development and testing of a general amber force field. J Comput Chem 25:1157–1174CrossRefGoogle Scholar
  46. Wiggers HJ, Rocha JR, Fernandes WB, Sesti-Costa R, Carneiro ZA, Cheleski J, da Silva ABF, Juliano L, Cezari MHS, Silva JS, McKerrow JH, Montanari CA (2013) Non-peptidic cruzain inhibitors with trypanocidal activity discovered by virtual screening and in vitro assay. PLoS Negl Trop Dis 7:e2370CrossRefGoogle Scholar
  47. Wild DJ (2005) MINITAB Release 14. J Chem Inf Model 45:212CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Renato A. Costa
    • 1
    • 2
  • Jorddy N. Cruz
    • 3
    Email author return OK on get
  • Fabiana C. A. Nascimento
    • 2
  • Sebastião G. Silva
    • 2
  • Silvana O. Silva
    • 2
  • Marlice C. Martelli
    • 2
  • Samira M. L. Carvalho
    • 2
  • Cleydson B. R. Santos
    • 4
  • Antonio M. J. C. Neto
    • 3
  • Davi S. B. Brasil
    • 2
  1. 1.Federal Institute of ParáParauapebasBrazil
  2. 2.Post-Graduate Program in ChemistryFederal University of ParáBelémBrazil
  3. 3.Laboratory of Preparation and Computation of NanomaterialsFederal University of ParáBelémBrazil
  4. 4.Laboratory of Modeling and Computational ChemistryFederal University of AmapáMacapáBrazil

Personalised recommendations